Dr Simone Ardern-Holmes

Clinical Lecturer
Paediatrics & Child Health, Children's Hospital, Westmead

Telephone 9845 1164
Fax 9845 1317

Map

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Fisher, M., Avery, R., Allen, J., Ardern-Holmes, S., Bilaniuk, L., Ferner, R., Gutmann, D., Listernick, R., Martin, S., Ullrich, N., et al (2013). Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology, 81(21 Suppl 1), S15-S24. [More Information]
  • Plotkin, S., Ardern-Holmes, S., Barker, F., Blakeley, J., Evans, D., Ferner, R., Hadlock, T., Halpin, C. (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology, 81(21 Suppl 1), S25-S32. [More Information]
  • Dombi, E., Ardern-Holmes, S., Babovic-Vuksanovic, D., Barker, F., Connor, S., Evans, D., Fisher, M., Goutagny, S., Harris, G., Jaramillo, D., et al (2013). Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology, 81(Suppl1), S33-S40. [More Information]
  • Ardern-Holmes, S., North, K. (2012). Treatment for plexiform neurofibromas in patients with NF1. The Lancet Oncology, 13(12), 1175-1176. [More Information]
  • Fisher, M., Loguidice, M., Gutmann, D., Listernick, R., Ferner, R., Ullrich, N., Packer, R., Tabori, U., Hoffman, R., Ardern-Holmes, S., et al (2012). Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology, 14(6), 790-797. [More Information]
  • Ardern-Holmes, S., North, K. (2011). Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2. Current Treatment Options in Neurology, 13(6), 529-543. [More Information]

2013

  • Fisher, M., Avery, R., Allen, J., Ardern-Holmes, S., Bilaniuk, L., Ferner, R., Gutmann, D., Listernick, R., Martin, S., Ullrich, N., et al (2013). Functional outcome measures for NF1-associated optic pathway glioma clinical trials. Neurology, 81(21 Suppl 1), S15-S24. [More Information]
  • Plotkin, S., Ardern-Holmes, S., Barker, F., Blakeley, J., Evans, D., Ferner, R., Hadlock, T., Halpin, C. (2013). Hearing and facial function outcomes for neurofibromatosis 2 clinical trials. Neurology, 81(21 Suppl 1), S25-S32. [More Information]
  • Dombi, E., Ardern-Holmes, S., Babovic-Vuksanovic, D., Barker, F., Connor, S., Evans, D., Fisher, M., Goutagny, S., Harris, G., Jaramillo, D., et al (2013). Recommendations for imaging tumor response in neurofibromatosis clinical trials. Neurology, 81(Suppl1), S33-S40. [More Information]

2012

  • Ardern-Holmes, S., North, K. (2012). Treatment for plexiform neurofibromas in patients with NF1. The Lancet Oncology, 13(12), 1175-1176. [More Information]
  • Fisher, M., Loguidice, M., Gutmann, D., Listernick, R., Ferner, R., Ullrich, N., Packer, R., Tabori, U., Hoffman, R., Ardern-Holmes, S., et al (2012). Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology, 14(6), 790-797. [More Information]

2011

  • Ardern-Holmes, S., North, K. (2011). Therapeutics for Childhood Neurofibromatosis Type 1 and Type 2. Current Treatment Options in Neurology, 13(6), 529-543. [More Information]

To update your profile click here. For support on your academic profile contact .